nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—FDPS—myometrium—uterine cancer	0.0215	0.125	CbGeAlD
Ibandronate—FDPS—uterine cervix—uterine cancer	0.0167	0.097	CbGeAlD
Ibandronate—FDPS—smooth muscle tissue—uterine cancer	0.0163	0.0943	CbGeAlD
Ibandronate—FDPS—decidua—uterine cancer	0.016	0.0924	CbGeAlD
Ibandronate—FDPS—renal system—uterine cancer	0.0157	0.0908	CbGeAlD
Ibandronate—FDPS—endometrium—uterine cancer	0.0151	0.0878	CbGeAlD
Ibandronate—FDPS—mammalian vulva—uterine cancer	0.0146	0.0849	CbGeAlD
Ibandronate—FDPS—uterus—uterine cancer	0.014	0.0809	CbGeAlD
Ibandronate—FDPS—female reproductive system—uterine cancer	0.0125	0.0727	CbGeAlD
Ibandronate—FDPS—female gonad—uterine cancer	0.0114	0.0661	CbGeAlD
Ibandronate—FDPS—vagina—uterine cancer	0.0113	0.0657	CbGeAlD
Ibandronate—FDPS—lymph node—uterine cancer	0.00734	0.0425	CbGeAlD
Ibandronate—Pulmonary oedema—Doxorubicin—uterine cancer	0.000999	0.00121	CcSEcCtD
Ibandronate—Dizziness—Progesterone—uterine cancer	0.000998	0.00121	CcSEcCtD
Ibandronate—Angiopathy—Etoposide—uterine cancer	0.000985	0.00119	CcSEcCtD
Ibandronate—Hypertonia—Doxorubicin—uterine cancer	0.000983	0.00119	CcSEcCtD
Ibandronate—Immune system disorder—Etoposide—uterine cancer	0.000981	0.00119	CcSEcCtD
Ibandronate—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000981	0.00119	CcSEcCtD
Ibandronate—Mediastinal disorder—Etoposide—uterine cancer	0.000979	0.00118	CcSEcCtD
Ibandronate—Chills—Etoposide—uterine cancer	0.000975	0.00118	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000971	0.00117	CcSEcCtD
Ibandronate—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000967	0.00117	CcSEcCtD
Ibandronate—Alopecia—Etoposide—uterine cancer	0.00096	0.00116	CcSEcCtD
Ibandronate—Vomiting—Progesterone—uterine cancer	0.000959	0.00116	CcSEcCtD
Ibandronate—Renal failure acute—Epirubicin—uterine cancer	0.000953	0.00115	CcSEcCtD
Ibandronate—Rash—Progesterone—uterine cancer	0.000951	0.00115	CcSEcCtD
Ibandronate—Dermatitis—Progesterone—uterine cancer	0.00095	0.00115	CcSEcCtD
Ibandronate—Headache—Progesterone—uterine cancer	0.000945	0.00114	CcSEcCtD
Ibandronate—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000935	0.00113	CcSEcCtD
Ibandronate—Decreased appetite—Dactinomycin—uterine cancer	0.000927	0.00112	CcSEcCtD
Ibandronate—Dysgeusia—Etoposide—uterine cancer	0.000926	0.00112	CcSEcCtD
Ibandronate—Renal impairment—Epirubicin—uterine cancer	0.000925	0.00112	CcSEcCtD
Ibandronate—Fatigue—Dactinomycin—uterine cancer	0.000919	0.00111	CcSEcCtD
Ibandronate—Back pain—Etoposide—uterine cancer	0.000915	0.00111	CcSEcCtD
Ibandronate—Pain—Dactinomycin—uterine cancer	0.000912	0.0011	CcSEcCtD
Ibandronate—Muscle spasms—Etoposide—uterine cancer	0.000909	0.0011	CcSEcCtD
Ibandronate—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000904	0.00109	CcSEcCtD
Ibandronate—Nausea—Progesterone—uterine cancer	0.000896	0.00108	CcSEcCtD
Ibandronate—Renal failure acute—Doxorubicin—uterine cancer	0.000882	0.00107	CcSEcCtD
Ibandronate—Pain in extremity—Epirubicin—uterine cancer	0.00088	0.00106	CcSEcCtD
Ibandronate—Osteoarthritis—Epirubicin—uterine cancer	0.00088	0.00106	CcSEcCtD
Ibandronate—Feeling abnormal—Dactinomycin—uterine cancer	0.000879	0.00106	CcSEcCtD
Ibandronate—Ill-defined disorder—Etoposide—uterine cancer	0.000877	0.00106	CcSEcCtD
Ibandronate—Anaemia—Etoposide—uterine cancer	0.000874	0.00106	CcSEcCtD
Ibandronate—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000872	0.00105	CcSEcCtD
Ibandronate—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000869	0.00105	CcSEcCtD
Ibandronate—Migraine—Epirubicin—uterine cancer	0.000866	0.00105	CcSEcCtD
Ibandronate—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000862	0.00104	CcSEcCtD
Ibandronate—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000861	0.00104	CcSEcCtD
Ibandronate—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000856	0.00103	CcSEcCtD
Ibandronate—Renal impairment—Doxorubicin—uterine cancer	0.000856	0.00103	CcSEcCtD
Ibandronate—Malaise—Etoposide—uterine cancer	0.000853	0.00103	CcSEcCtD
Ibandronate—Face oedema—Epirubicin—uterine cancer	0.00085	0.00103	CcSEcCtD
Ibandronate—Vertigo—Etoposide—uterine cancer	0.00085	0.00103	CcSEcCtD
Ibandronate—Abdominal pain—Dactinomycin—uterine cancer	0.000843	0.00102	CcSEcCtD
Ibandronate—Body temperature increased—Dactinomycin—uterine cancer	0.000843	0.00102	CcSEcCtD
Ibandronate—Blood creatinine increased—Epirubicin—uterine cancer	0.000825	0.000996	CcSEcCtD
Ibandronate—Hypertension—Etoposide—uterine cancer	0.000816	0.000987	CcSEcCtD
Ibandronate—Pain in extremity—Doxorubicin—uterine cancer	0.000814	0.000984	CcSEcCtD
Ibandronate—Osteoarthritis—Doxorubicin—uterine cancer	0.000814	0.000984	CcSEcCtD
Ibandronate—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000812	0.000981	CcSEcCtD
Ibandronate—Chest pain—Etoposide—uterine cancer	0.000805	0.000973	CcSEcCtD
Ibandronate—Abdominal pain upper—Epirubicin—uterine cancer	0.000804	0.000971	CcSEcCtD
Ibandronate—Migraine—Doxorubicin—uterine cancer	0.000802	0.000969	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000799	0.000966	CcSEcCtD
Ibandronate—Discomfort—Etoposide—uterine cancer	0.000795	0.000961	CcSEcCtD
Ibandronate—Breast disorder—Epirubicin—uterine cancer	0.000795	0.000961	CcSEcCtD
Ibandronate—Nasopharyngitis—Epirubicin—uterine cancer	0.000787	0.000951	CcSEcCtD
Ibandronate—Face oedema—Doxorubicin—uterine cancer	0.000786	0.00095	CcSEcCtD
Ibandronate—Hypersensitivity—Dactinomycin—uterine cancer	0.000786	0.000949	CcSEcCtD
Ibandronate—Gastritis—Epirubicin—uterine cancer	0.000779	0.000941	CcSEcCtD
Ibandronate—Anaphylactic shock—Etoposide—uterine cancer	0.000772	0.000933	CcSEcCtD
Ibandronate—Infection—Etoposide—uterine cancer	0.000767	0.000927	CcSEcCtD
Ibandronate—Asthenia—Dactinomycin—uterine cancer	0.000765	0.000925	CcSEcCtD
Ibandronate—Blood creatinine increased—Doxorubicin—uterine cancer	0.000763	0.000922	CcSEcCtD
Ibandronate—Dysphagia—Epirubicin—uterine cancer	0.000761	0.000919	CcSEcCtD
Ibandronate—Influenza—Epirubicin—uterine cancer	0.000761	0.000919	CcSEcCtD
Ibandronate—Asthma—Epirubicin—uterine cancer	0.000761	0.000919	CcSEcCtD
Ibandronate—Skin disorder—Etoposide—uterine cancer	0.00075	0.000906	CcSEcCtD
Ibandronate—Hyperhidrosis—Etoposide—uterine cancer	0.000746	0.000902	CcSEcCtD
Ibandronate—Abdominal pain upper—Doxorubicin—uterine cancer	0.000744	0.000899	CcSEcCtD
Ibandronate—Breast disorder—Doxorubicin—uterine cancer	0.000736	0.000889	CcSEcCtD
Ibandronate—Bronchitis—Epirubicin—uterine cancer	0.000732	0.000884	CcSEcCtD
Ibandronate—Diarrhoea—Dactinomycin—uterine cancer	0.00073	0.000882	CcSEcCtD
Ibandronate—Nasopharyngitis—Doxorubicin—uterine cancer	0.000728	0.00088	CcSEcCtD
Ibandronate—Gastritis—Doxorubicin—uterine cancer	0.000721	0.000871	CcSEcCtD
Ibandronate—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000707	0.000854	CcSEcCtD
Ibandronate—Dysphagia—Doxorubicin—uterine cancer	0.000704	0.000851	CcSEcCtD
Ibandronate—Influenza—Doxorubicin—uterine cancer	0.000704	0.000851	CcSEcCtD
Ibandronate—Asthma—Doxorubicin—uterine cancer	0.000704	0.000851	CcSEcCtD
Ibandronate—Paraesthesia—Etoposide—uterine cancer	0.000693	0.000837	CcSEcCtD
Ibandronate—Weight decreased—Epirubicin—uterine cancer	0.000688	0.000832	CcSEcCtD
Ibandronate—Pneumonia—Epirubicin—uterine cancer	0.000682	0.000824	CcSEcCtD
Ibandronate—Infestation NOS—Epirubicin—uterine cancer	0.000678	0.00082	CcSEcCtD
Ibandronate—Infestation—Epirubicin—uterine cancer	0.000678	0.00082	CcSEcCtD
Ibandronate—Vomiting—Dactinomycin—uterine cancer	0.000678	0.000819	CcSEcCtD
Ibandronate—Bronchitis—Doxorubicin—uterine cancer	0.000677	0.000818	CcSEcCtD
Ibandronate—Rash—Dactinomycin—uterine cancer	0.000672	0.000812	CcSEcCtD
Ibandronate—Decreased appetite—Etoposide—uterine cancer	0.000671	0.000811	CcSEcCtD
Ibandronate—Renal failure—Epirubicin—uterine cancer	0.000667	0.000806	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Etoposide—uterine cancer	0.000666	0.000805	CcSEcCtD
Ibandronate—Fatigue—Etoposide—uterine cancer	0.000665	0.000804	CcSEcCtD
Ibandronate—Stomatitis—Epirubicin—uterine cancer	0.000661	0.000799	CcSEcCtD
Ibandronate—Constipation—Etoposide—uterine cancer	0.00066	0.000798	CcSEcCtD
Ibandronate—Pain—Etoposide—uterine cancer	0.00066	0.000798	CcSEcCtD
Ibandronate—Urinary tract infection—Epirubicin—uterine cancer	0.000659	0.000797	CcSEcCtD
Ibandronate—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000654	0.000791	CcSEcCtD
Ibandronate—Sweating—Epirubicin—uterine cancer	0.00065	0.000786	CcSEcCtD
Ibandronate—Hepatobiliary disease—Epirubicin—uterine cancer	0.000641	0.000775	CcSEcCtD
Ibandronate—Weight decreased—Doxorubicin—uterine cancer	0.000637	0.00077	CcSEcCtD
Ibandronate—Feeling abnormal—Etoposide—uterine cancer	0.000636	0.000769	CcSEcCtD
Ibandronate—Nausea—Dactinomycin—uterine cancer	0.000633	0.000765	CcSEcCtD
Ibandronate—Pneumonia—Doxorubicin—uterine cancer	0.000631	0.000763	CcSEcCtD
Ibandronate—Gastrointestinal pain—Etoposide—uterine cancer	0.000631	0.000763	CcSEcCtD
Ibandronate—Infestation—Doxorubicin—uterine cancer	0.000628	0.000758	CcSEcCtD
Ibandronate—Infestation NOS—Doxorubicin—uterine cancer	0.000628	0.000758	CcSEcCtD
Ibandronate—Renal failure—Doxorubicin—uterine cancer	0.000617	0.000746	CcSEcCtD
Ibandronate—Urticaria—Etoposide—uterine cancer	0.000613	0.000741	CcSEcCtD
Ibandronate—Haemoglobin—Epirubicin—uterine cancer	0.000612	0.00074	CcSEcCtD
Ibandronate—Stomatitis—Doxorubicin—uterine cancer	0.000612	0.000739	CcSEcCtD
Ibandronate—Abdominal pain—Etoposide—uterine cancer	0.00061	0.000737	CcSEcCtD
Ibandronate—Body temperature increased—Etoposide—uterine cancer	0.00061	0.000737	CcSEcCtD
Ibandronate—Urinary tract infection—Doxorubicin—uterine cancer	0.00061	0.000737	CcSEcCtD
Ibandronate—Haemorrhage—Epirubicin—uterine cancer	0.000609	0.000736	CcSEcCtD
Ibandronate—Pharyngitis—Epirubicin—uterine cancer	0.000604	0.00073	CcSEcCtD
Ibandronate—Sweating—Doxorubicin—uterine cancer	0.000602	0.000727	CcSEcCtD
Ibandronate—Urinary tract disorder—Epirubicin—uterine cancer	0.000601	0.000727	CcSEcCtD
Ibandronate—Oedema peripheral—Epirubicin—uterine cancer	0.0006	0.000725	CcSEcCtD
Ibandronate—Connective tissue disorder—Epirubicin—uterine cancer	0.000598	0.000723	CcSEcCtD
Ibandronate—Urethral disorder—Epirubicin—uterine cancer	0.000597	0.000721	CcSEcCtD
Ibandronate—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000594	0.000717	CcSEcCtD
Ibandronate—Eye disorder—Epirubicin—uterine cancer	0.000569	0.000688	CcSEcCtD
Ibandronate—Hypersensitivity—Etoposide—uterine cancer	0.000569	0.000687	CcSEcCtD
Ibandronate—Haemoglobin—Doxorubicin—uterine cancer	0.000566	0.000684	CcSEcCtD
Ibandronate—Cardiac disorder—Epirubicin—uterine cancer	0.000565	0.000683	CcSEcCtD
Ibandronate—Haemorrhage—Doxorubicin—uterine cancer	0.000563	0.000681	CcSEcCtD
Ibandronate—Pharyngitis—Doxorubicin—uterine cancer	0.000559	0.000676	CcSEcCtD
Ibandronate—Urinary tract disorder—Doxorubicin—uterine cancer	0.000556	0.000672	CcSEcCtD
Ibandronate—Oedema peripheral—Doxorubicin—uterine cancer	0.000555	0.000671	CcSEcCtD
Ibandronate—Asthenia—Etoposide—uterine cancer	0.000554	0.000669	CcSEcCtD
Ibandronate—Connective tissue disorder—Doxorubicin—uterine cancer	0.000554	0.000669	CcSEcCtD
Ibandronate—Angiopathy—Epirubicin—uterine cancer	0.000552	0.000668	CcSEcCtD
Ibandronate—Urethral disorder—Doxorubicin—uterine cancer	0.000552	0.000667	CcSEcCtD
Ibandronate—Immune system disorder—Epirubicin—uterine cancer	0.00055	0.000665	CcSEcCtD
Ibandronate—Mediastinal disorder—Epirubicin—uterine cancer	0.000549	0.000663	CcSEcCtD
Ibandronate—Chills—Epirubicin—uterine cancer	0.000546	0.00066	CcSEcCtD
Ibandronate—Pruritus—Etoposide—uterine cancer	0.000546	0.00066	CcSEcCtD
Ibandronate—Alopecia—Epirubicin—uterine cancer	0.000538	0.00065	CcSEcCtD
Ibandronate—Mental disorder—Epirubicin—uterine cancer	0.000533	0.000645	CcSEcCtD
Ibandronate—Erythema—Epirubicin—uterine cancer	0.00053	0.000641	CcSEcCtD
Ibandronate—Malnutrition—Epirubicin—uterine cancer	0.00053	0.000641	CcSEcCtD
Ibandronate—Diarrhoea—Etoposide—uterine cancer	0.000528	0.000638	CcSEcCtD
Ibandronate—Eye disorder—Doxorubicin—uterine cancer	0.000526	0.000636	CcSEcCtD
Ibandronate—Cardiac disorder—Doxorubicin—uterine cancer	0.000523	0.000632	CcSEcCtD
Ibandronate—Flatulence—Epirubicin—uterine cancer	0.000522	0.000631	CcSEcCtD
Ibandronate—Dysgeusia—Epirubicin—uterine cancer	0.000519	0.000627	CcSEcCtD
Ibandronate—Back pain—Epirubicin—uterine cancer	0.000513	0.00062	CcSEcCtD
Ibandronate—Angiopathy—Doxorubicin—uterine cancer	0.000511	0.000618	CcSEcCtD
Ibandronate—Dizziness—Etoposide—uterine cancer	0.00051	0.000617	CcSEcCtD
Ibandronate—Muscle spasms—Epirubicin—uterine cancer	0.00051	0.000616	CcSEcCtD
Ibandronate—Immune system disorder—Doxorubicin—uterine cancer	0.000509	0.000615	CcSEcCtD
Ibandronate—Mediastinal disorder—Doxorubicin—uterine cancer	0.000508	0.000614	CcSEcCtD
Ibandronate—Chills—Doxorubicin—uterine cancer	0.000505	0.000611	CcSEcCtD
Ibandronate—Alopecia—Doxorubicin—uterine cancer	0.000498	0.000602	CcSEcCtD
Ibandronate—Mental disorder—Doxorubicin—uterine cancer	0.000494	0.000597	CcSEcCtD
Ibandronate—Ill-defined disorder—Epirubicin—uterine cancer	0.000492	0.000594	CcSEcCtD
Ibandronate—Vomiting—Etoposide—uterine cancer	0.000491	0.000593	CcSEcCtD
Ibandronate—Erythema—Doxorubicin—uterine cancer	0.00049	0.000593	CcSEcCtD
Ibandronate—Malnutrition—Doxorubicin—uterine cancer	0.00049	0.000593	CcSEcCtD
Ibandronate—Anaemia—Epirubicin—uterine cancer	0.00049	0.000592	CcSEcCtD
Ibandronate—Rash—Etoposide—uterine cancer	0.000487	0.000588	CcSEcCtD
Ibandronate—Dermatitis—Etoposide—uterine cancer	0.000486	0.000588	CcSEcCtD
Ibandronate—Headache—Etoposide—uterine cancer	0.000483	0.000584	CcSEcCtD
Ibandronate—Flatulence—Doxorubicin—uterine cancer	0.000483	0.000584	CcSEcCtD
Ibandronate—Dysgeusia—Doxorubicin—uterine cancer	0.00048	0.00058	CcSEcCtD
Ibandronate—Malaise—Epirubicin—uterine cancer	0.000478	0.000578	CcSEcCtD
Ibandronate—Vertigo—Epirubicin—uterine cancer	0.000476	0.000576	CcSEcCtD
Ibandronate—Back pain—Doxorubicin—uterine cancer	0.000474	0.000573	CcSEcCtD
Ibandronate—Muscle spasms—Doxorubicin—uterine cancer	0.000472	0.00057	CcSEcCtD
Ibandronate—Palpitations—Epirubicin—uterine cancer	0.000468	0.000566	CcSEcCtD
Ibandronate—Nausea—Etoposide—uterine cancer	0.000458	0.000554	CcSEcCtD
Ibandronate—Hypertension—Epirubicin—uterine cancer	0.000458	0.000553	CcSEcCtD
Ibandronate—Ill-defined disorder—Doxorubicin—uterine cancer	0.000455	0.00055	CcSEcCtD
Ibandronate—Anaemia—Doxorubicin—uterine cancer	0.000453	0.000548	CcSEcCtD
Ibandronate—Myalgia—Epirubicin—uterine cancer	0.000451	0.000545	CcSEcCtD
Ibandronate—Chest pain—Epirubicin—uterine cancer	0.000451	0.000545	CcSEcCtD
Ibandronate—Arthralgia—Epirubicin—uterine cancer	0.000451	0.000545	CcSEcCtD
Ibandronate—Anxiety—Epirubicin—uterine cancer	0.00045	0.000543	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000448	0.000542	CcSEcCtD
Ibandronate—Discomfort—Epirubicin—uterine cancer	0.000446	0.000539	CcSEcCtD
Ibandronate—Malaise—Doxorubicin—uterine cancer	0.000442	0.000534	CcSEcCtD
Ibandronate—Dry mouth—Epirubicin—uterine cancer	0.000441	0.000533	CcSEcCtD
Ibandronate—Vertigo—Doxorubicin—uterine cancer	0.000441	0.000533	CcSEcCtD
Ibandronate—Palpitations—Doxorubicin—uterine cancer	0.000433	0.000524	CcSEcCtD
Ibandronate—Anaphylactic shock—Epirubicin—uterine cancer	0.000433	0.000523	CcSEcCtD
Ibandronate—Infection—Epirubicin—uterine cancer	0.00043	0.000519	CcSEcCtD
Ibandronate—Shock—Epirubicin—uterine cancer	0.000426	0.000514	CcSEcCtD
Ibandronate—Nervous system disorder—Epirubicin—uterine cancer	0.000424	0.000513	CcSEcCtD
Ibandronate—Hypertension—Doxorubicin—uterine cancer	0.000423	0.000512	CcSEcCtD
Ibandronate—Skin disorder—Epirubicin—uterine cancer	0.00042	0.000508	CcSEcCtD
Ibandronate—Hyperhidrosis—Epirubicin—uterine cancer	0.000418	0.000505	CcSEcCtD
Ibandronate—Chest pain—Doxorubicin—uterine cancer	0.000418	0.000505	CcSEcCtD
Ibandronate—Arthralgia—Doxorubicin—uterine cancer	0.000418	0.000505	CcSEcCtD
Ibandronate—Myalgia—Doxorubicin—uterine cancer	0.000418	0.000505	CcSEcCtD
Ibandronate—Anxiety—Doxorubicin—uterine cancer	0.000416	0.000503	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000415	0.000501	CcSEcCtD
Ibandronate—Discomfort—Doxorubicin—uterine cancer	0.000413	0.000499	CcSEcCtD
Ibandronate—Dry mouth—Doxorubicin—uterine cancer	0.000408	0.000493	CcSEcCtD
Ibandronate—Anaphylactic shock—Doxorubicin—uterine cancer	0.0004	0.000484	CcSEcCtD
Ibandronate—Infection—Doxorubicin—uterine cancer	0.000398	0.000481	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000394	0.000476	CcSEcCtD
Ibandronate—Shock—Doxorubicin—uterine cancer	0.000394	0.000476	CcSEcCtD
Ibandronate—Nervous system disorder—Doxorubicin—uterine cancer	0.000393	0.000474	CcSEcCtD
Ibandronate—Insomnia—Epirubicin—uterine cancer	0.000391	0.000473	CcSEcCtD
Ibandronate—Skin disorder—Doxorubicin—uterine cancer	0.000389	0.00047	CcSEcCtD
Ibandronate—Paraesthesia—Epirubicin—uterine cancer	0.000388	0.000469	CcSEcCtD
Ibandronate—Hyperhidrosis—Doxorubicin—uterine cancer	0.000387	0.000468	CcSEcCtD
Ibandronate—Dyspepsia—Epirubicin—uterine cancer	0.000381	0.00046	CcSEcCtD
Ibandronate—Decreased appetite—Epirubicin—uterine cancer	0.000376	0.000454	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000373	0.000451	CcSEcCtD
Ibandronate—Fatigue—Epirubicin—uterine cancer	0.000373	0.000451	CcSEcCtD
Ibandronate—Constipation—Epirubicin—uterine cancer	0.00037	0.000447	CcSEcCtD
Ibandronate—Pain—Epirubicin—uterine cancer	0.00037	0.000447	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000365	0.000441	CcSEcCtD
Ibandronate—Insomnia—Doxorubicin—uterine cancer	0.000362	0.000438	CcSEcCtD
Ibandronate—Paraesthesia—Doxorubicin—uterine cancer	0.000359	0.000434	CcSEcCtD
Ibandronate—Feeling abnormal—Epirubicin—uterine cancer	0.000356	0.000431	CcSEcCtD
Ibandronate—Gastrointestinal pain—Epirubicin—uterine cancer	0.000354	0.000427	CcSEcCtD
Ibandronate—Dyspepsia—Doxorubicin—uterine cancer	0.000352	0.000426	CcSEcCtD
Ibandronate—Decreased appetite—Doxorubicin—uterine cancer	0.000348	0.000421	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000346	0.000418	CcSEcCtD
Ibandronate—Fatigue—Doxorubicin—uterine cancer	0.000345	0.000417	CcSEcCtD
Ibandronate—Urticaria—Epirubicin—uterine cancer	0.000344	0.000415	CcSEcCtD
Ibandronate—Constipation—Doxorubicin—uterine cancer	0.000342	0.000414	CcSEcCtD
Ibandronate—Pain—Doxorubicin—uterine cancer	0.000342	0.000414	CcSEcCtD
Ibandronate—Abdominal pain—Epirubicin—uterine cancer	0.000342	0.000413	CcSEcCtD
Ibandronate—Body temperature increased—Epirubicin—uterine cancer	0.000342	0.000413	CcSEcCtD
Ibandronate—Feeling abnormal—Doxorubicin—uterine cancer	0.00033	0.000399	CcSEcCtD
Ibandronate—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000327	0.000396	CcSEcCtD
Ibandronate—Hypersensitivity—Epirubicin—uterine cancer	0.000319	0.000385	CcSEcCtD
Ibandronate—Urticaria—Doxorubicin—uterine cancer	0.000318	0.000384	CcSEcCtD
Ibandronate—Abdominal pain—Doxorubicin—uterine cancer	0.000316	0.000382	CcSEcCtD
Ibandronate—Body temperature increased—Doxorubicin—uterine cancer	0.000316	0.000382	CcSEcCtD
Ibandronate—Asthenia—Epirubicin—uterine cancer	0.00031	0.000375	CcSEcCtD
Ibandronate—Pruritus—Epirubicin—uterine cancer	0.000306	0.00037	CcSEcCtD
Ibandronate—Diarrhoea—Epirubicin—uterine cancer	0.000296	0.000358	CcSEcCtD
Ibandronate—Hypersensitivity—Doxorubicin—uterine cancer	0.000295	0.000356	CcSEcCtD
Ibandronate—Asthenia—Doxorubicin—uterine cancer	0.000287	0.000347	CcSEcCtD
Ibandronate—Dizziness—Epirubicin—uterine cancer	0.000286	0.000346	CcSEcCtD
Ibandronate—Pruritus—Doxorubicin—uterine cancer	0.000283	0.000342	CcSEcCtD
Ibandronate—Vomiting—Epirubicin—uterine cancer	0.000275	0.000332	CcSEcCtD
Ibandronate—Diarrhoea—Doxorubicin—uterine cancer	0.000274	0.000331	CcSEcCtD
Ibandronate—Rash—Epirubicin—uterine cancer	0.000273	0.00033	CcSEcCtD
Ibandronate—Dermatitis—Epirubicin—uterine cancer	0.000272	0.000329	CcSEcCtD
Ibandronate—Headache—Epirubicin—uterine cancer	0.000271	0.000328	CcSEcCtD
Ibandronate—Dizziness—Doxorubicin—uterine cancer	0.000265	0.00032	CcSEcCtD
Ibandronate—Nausea—Epirubicin—uterine cancer	0.000257	0.000311	CcSEcCtD
Ibandronate—Vomiting—Doxorubicin—uterine cancer	0.000254	0.000308	CcSEcCtD
Ibandronate—Rash—Doxorubicin—uterine cancer	0.000252	0.000305	CcSEcCtD
Ibandronate—Dermatitis—Doxorubicin—uterine cancer	0.000252	0.000305	CcSEcCtD
Ibandronate—Headache—Doxorubicin—uterine cancer	0.000251	0.000303	CcSEcCtD
Ibandronate—Nausea—Doxorubicin—uterine cancer	0.000238	0.000287	CcSEcCtD
